You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Biotech IPO boom likely to continue in 2014

View is generally rosy — unless stimulus funds taper off

CAMBRIDGE — The boom in initial public offerings by biotech startups, which took many by surprise this year, looks likely to continue into 2014. But it could lose some steam if the Federal Reserve starts to withdraw the stimulus powering financial markets.

That was the view of industry dealmakers assessing the IPO market Monday during a panel discussion sponsored by the New England Healthcare Executives Group, a networking organization in the biotech and medical technology businesses.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week